Neoadjuvant Low-Dose Radiotherapy Combined With Adebrelimab and Single-Agent Albumin-Bound Paclitaxel Chemotherapy for Early-Stage Oral Squamous Cell Carcinoma: A Prospective, Single-Arm Clinical Trial

NCT07007364 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Early-Stage Oral Squamous Cell Carcinoma

Interventions

DRUG: Adebrelimab Combined With Albumin Paclitaxel

Sponsor

Jun Jia